NCT05553938View on ClinicalTrials.gov

Effects of Acute and Chronic Empagliflozin Heart Failure

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Heart Failure
Interventions
DRUG

Empagliflozin 10 mg

Empagliflozin 10mg

DRUG

Placebo

Empagliflozin matched placebo tablet

Trial Locations (2)

06520

RECRUITING

Yale New Haven Hospital, New Haven

RECRUITING

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER